カテゴリー： GlobalInfoResearch, 世界, 産業機械/建設

初代肝細胞の世界市場2022：ヒト初代細胞、動物初代細胞

◆英語タイトル：Global Primary Hepatocytes Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO17012 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：123 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：産業機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

初代肝細胞市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の初代肝細胞の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

初代肝細胞市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ヒト初代細胞、動物初代細胞

用途別セグメントは次のように区分されます。
・ライフサイエンス研究企業、研究機関、その他

世界の初代肝細胞市場の主要な市場プレーヤーは以下のとおりです。
・Thermo Fisher Scientific, Inc.、Merck KGaA、Lonza、Cell Biologics, Inc.、PromoCell GmbH、HemaCare Corporation、ZenBio, Inc.、STEMCELL Technologies, Inc.、Corning Incorporated、AllCells、Axol Bioscience Ltd.、iXCells Biotechnologies、Neuromics、StemExpress、BioIVT、ScienCell Research Laboratories, Inc.、PPA Research Group, Inc.、Creative Bioarray、BPS Bioscience, Inc.、Epithelix Sàrl、ReachBio LLC、AcceGen、Sekisui XenoTech, LLC、Biopredic International

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、初代肝細胞製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な初代肝細胞メーカーの企業概要、2019年～2022年までの初代肝細胞の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な初代肝細胞メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別初代肝細胞の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの初代肝細胞の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での初代肝細胞市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および初代肝細胞の産業チェーンを掲載しています。
・第13、14、15章では、初代肝細胞の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 初代肝細胞の概要
- 種類別分析（2017年vs2021年vs2028年）：ヒト初代細胞、動物初代細胞
- 用途別分析（2017年vs2021年vs2028年）：ライフサイエンス研究企業、研究機関、その他
- 世界の初代肝細胞市場規模・予測
- 世界の初代肝細胞生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Thermo Fisher Scientific, Inc.、Merck KGaA、Lonza、Cell Biologics, Inc.、PromoCell GmbH、HemaCare Corporation、ZenBio, Inc.、STEMCELL Technologies, Inc.、Corning Incorporated、AllCells、Axol Bioscience Ltd.、iXCells Biotechnologies、Neuromics、StemExpress、BioIVT、ScienCell Research Laboratories, Inc.、PPA Research Group, Inc.、Creative Bioarray、BPS Bioscience, Inc.、Epithelix Sàrl、ReachBio LLC、AcceGen、Sekisui XenoTech, LLC、Biopredic International
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ヒト初代細胞、動物初代細胞
・用途別分析2017年-2028年：ライフサイエンス研究企業、研究機関、その他
・初代肝細胞の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・初代肝細胞のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・初代肝細胞のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・初代肝細胞の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・初代肝細胞の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Primary Hepatocytes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Primary Hepatocytes market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Life Science Research Companies accounting for % of the Primary Hepatocytes global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Human Primary Cells segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Primary Hepatocytes include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., and PromoCell GmbH, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Primary Hepatocytes market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Human Primary Cells
Animal Primary Cells
Market segment by Application can be divided into
Life Science Research Companies
Research Institutes
Others
The key market players for global Primary Hepatocytes market are listed below:
Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza
Cell Biologics, Inc.
PromoCell GmbH
HemaCare Corporation
ZenBio, Inc.
STEMCELL Technologies, Inc.
Corning Incorporated
AllCells
Axol Bioscience Ltd.
iXCells Biotechnologies
Neuromics
StemExpress
BioIVT
ScienCell Research Laboratories, Inc.
PPA Research Group, Inc.
Creative Bioarray
BPS Bioscience, Inc.
Epithelix Sàrl
ReachBio LLC
AcceGen
Sekisui XenoTech, LLC
Biopredic International
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Primary Hepatocytes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Primary Hepatocytes, with price, sales, revenue and global market share of Primary Hepatocytes from 2019 to 2022.
Chapter 3, the Primary Hepatocytes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primary Hepatocytes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Primary Hepatocytes market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Primary Hepatocytes.
Chapter 13, 14, and 15, to describe Primary Hepatocytes sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Primary Hepatocytes Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Primary Hepatocytes Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Human Primary Cells
1.2.3 Animal Primary Cells
1.3 Market Analysis by Application
1.3.1 Overview: Global Primary Hepatocytes Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Life Science Research Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Global Primary Hepatocytes Market Size & Forecast
1.4.1 Global Primary Hepatocytes Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Primary Hepatocytes Sales in Volume (2017-2028)
1.4.3 Global Primary Hepatocytes Price (2017-2028)
1.5 Global Primary Hepatocytes Production Capacity Analysis
1.5.1 Global Primary Hepatocytes Total Production Capacity (2017-2028)
1.5.2 Global Primary Hepatocytes Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Primary Hepatocytes Market Drivers
1.6.2 Primary Hepatocytes Market Restraints
1.6.3 Primary Hepatocytes Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific, Inc.
2.1.1 Thermo Fisher Scientific, Inc. Details
2.1.2 Thermo Fisher Scientific, Inc. Major Business
2.1.3 Thermo Fisher Scientific, Inc. Primary Hepatocytes Product and Services
2.1.4 Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Primary Hepatocytes Product and Services
2.2.4 Merck KGaA Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Lonza
2.3.1 Lonza Details
2.3.2 Lonza Major Business
2.3.3 Lonza Primary Hepatocytes Product and Services
2.3.4 Lonza Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cell Biologics, Inc.
2.4.1 Cell Biologics, Inc. Details
2.4.2 Cell Biologics, Inc. Major Business
2.4.3 Cell Biologics, Inc. Primary Hepatocytes Product and Services
2.4.4 Cell Biologics, Inc. Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 PromoCell GmbH
2.5.1 PromoCell GmbH Details
2.5.2 PromoCell GmbH Major Business
2.5.3 PromoCell GmbH Primary Hepatocytes Product and Services
2.5.4 PromoCell GmbH Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 HemaCare Corporation
2.6.1 HemaCare Corporation Details
2.6.2 HemaCare Corporation Major Business
2.6.3 HemaCare Corporation Primary Hepatocytes Product and Services
2.6.4 HemaCare Corporation Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 ZenBio, Inc.
2.7.1 ZenBio, Inc. Details
2.7.2 ZenBio, Inc. Major Business
2.7.3 ZenBio, Inc. Primary Hepatocytes Product and Services
2.7.4 ZenBio, Inc. Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 STEMCELL Technologies, Inc.
2.8.1 STEMCELL Technologies, Inc. Details
2.8.2 STEMCELL Technologies, Inc. Major Business
2.8.3 STEMCELL Technologies, Inc. Primary Hepatocytes Product and Services
2.8.4 STEMCELL Technologies, Inc. Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Corning Incorporated
2.9.1 Corning Incorporated Details
2.9.2 Corning Incorporated Major Business
2.9.3 Corning Incorporated Primary Hepatocytes Product and Services
2.9.4 Corning Incorporated Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 AllCells
2.10.1 AllCells Details
2.10.2 AllCells Major Business
2.10.3 AllCells Primary Hepatocytes Product and Services
2.10.4 AllCells Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Axol Bioscience Ltd.
2.11.1 Axol Bioscience Ltd. Details
2.11.2 Axol Bioscience Ltd. Major Business
2.11.3 Axol Bioscience Ltd. Primary Hepatocytes Product and Services
2.11.4 Axol Bioscience Ltd. Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 iXCells Biotechnologies
2.12.1 iXCells Biotechnologies Details
2.12.2 iXCells Biotechnologies Major Business
2.12.3 iXCells Biotechnologies Primary Hepatocytes Product and Services
2.12.4 iXCells Biotechnologies Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Neuromics
2.13.1 Neuromics Details
2.13.2 Neuromics Major Business
2.13.3 Neuromics Primary Hepatocytes Product and Services
2.13.4 Neuromics Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 StemExpress
2.14.1 StemExpress Details
2.14.2 StemExpress Major Business
2.14.3 StemExpress Primary Hepatocytes Product and Services
2.14.4 StemExpress Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 BioIVT
2.15.1 BioIVT Details
2.15.2 BioIVT Major Business
2.15.3 BioIVT Primary Hepatocytes Product and Services
2.15.4 BioIVT Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 ScienCell Research Laboratories, Inc.
2.16.1 ScienCell Research Laboratories, Inc. Details
2.16.2 ScienCell Research Laboratories, Inc. Major Business
2.16.3 ScienCell Research Laboratories, Inc. Primary Hepatocytes Product and Services
2.16.4 ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 PPA Research Group, Inc.
2.17.1 PPA Research Group, Inc. Details
2.17.2 PPA Research Group, Inc. Major Business
2.17.3 PPA Research Group, Inc. Primary Hepatocytes Product and Services
2.17.4 PPA Research Group, Inc. Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Creative Bioarray
2.18.1 Creative Bioarray Details
2.18.2 Creative Bioarray Major Business
2.18.3 Creative Bioarray Primary Hepatocytes Product and Services
2.18.4 Creative Bioarray Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 BPS Bioscience, Inc.
2.19.1 BPS Bioscience, Inc. Details
2.19.2 BPS Bioscience, Inc. Major Business
2.19.3 BPS Bioscience, Inc. Primary Hepatocytes Product and Services
2.19.4 BPS Bioscience, Inc. Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Epithelix Sàrl
2.20.1 Epithelix Sàrl Details
2.20.2 Epithelix Sàrl Major Business
2.20.3 Epithelix Sàrl Primary Hepatocytes Product and Services
2.20.4 Epithelix Sàrl Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 ReachBio LLC
2.21.1 ReachBio LLC Details
2.21.2 ReachBio LLC Major Business
2.21.3 ReachBio LLC Primary Hepatocytes Product and Services
2.21.4 ReachBio LLC Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 AcceGen
2.22.1 AcceGen Details
2.22.2 AcceGen Major Business
2.22.3 AcceGen Primary Hepatocytes Product and Services
2.22.4 AcceGen Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Sekisui XenoTech, LLC
2.23.1 Sekisui XenoTech, LLC Details
2.23.2 Sekisui XenoTech, LLC Major Business
2.23.3 Sekisui XenoTech, LLC Primary Hepatocytes Product and Services
2.23.4 Sekisui XenoTech, LLC Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Biopredic International
2.24.1 Biopredic International Details
2.24.2 Biopredic International Major Business
2.24.3 Biopredic International Primary Hepatocytes Product and Services
2.24.4 Biopredic International Primary Hepatocytes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Primary Hepatocytes Breakdown Data by Manufacturer
3.1 Global Primary Hepatocytes Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Primary Hepatocytes Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Primary Hepatocytes
3.4 Market Concentration Rate
3.4.1 Top 3 Primary Hepatocytes Manufacturer Market Share in 2021
3.4.2 Top 6 Primary Hepatocytes Manufacturer Market Share in 2021
3.5 Global Primary Hepatocytes Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Primary Hepatocytes Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Primary Hepatocytes Market Size by Region
4.1.1 Global Primary Hepatocytes Sales in Volume by Region (2017-2028)
4.1.2 Global Primary Hepatocytes Revenue by Region (2017-2028)
4.2 North America Primary Hepatocytes Revenue (2017-2028)
4.3 Europe Primary Hepatocytes Revenue (2017-2028)
4.4 Asia-Pacific Primary Hepatocytes Revenue (2017-2028)
4.5 South America Primary Hepatocytes Revenue (2017-2028)
4.6 Middle East and Africa Primary Hepatocytes Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Primary Hepatocytes Sales in Volume by Type (2017-2028)
5.2 Global Primary Hepatocytes Revenue by Type (2017-2028)
5.3 Global Primary Hepatocytes Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Primary Hepatocytes Sales in Volume by Application (2017-2028)
6.2 Global Primary Hepatocytes Revenue by Application (2017-2028)
6.3 Global Primary Hepatocytes Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Primary Hepatocytes Sales by Type (2017-2028)
7.2 North America Primary Hepatocytes Sales by Application (2017-2028)
7.3 North America Primary Hepatocytes Market Size by Country
7.3.1 North America Primary Hepatocytes Sales in Volume by Country (2017-2028)
7.3.2 North America Primary Hepatocytes Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Primary Hepatocytes Sales by Type (2017-2028)
8.2 Europe Primary Hepatocytes Sales by Application (2017-2028)
8.3 Europe Primary Hepatocytes Market Size by Country
8.3.1 Europe Primary Hepatocytes Sales in Volume by Country (2017-2028)
8.3.2 Europe Primary Hepatocytes Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Primary Hepatocytes Sales by Type (2017-2028)
9.2 Asia-Pacific Primary Hepatocytes Sales by Application (2017-2028)
9.3 Asia-Pacific Primary Hepatocytes Market Size by Region
9.3.1 Asia-Pacific Primary Hepatocytes Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Primary Hepatocytes Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Primary Hepatocytes Sales by Type (2017-2028)
10.2 South America Primary Hepatocytes Sales by Application (2017-2028)
10.3 South America Primary Hepatocytes Market Size by Country
10.3.1 South America Primary Hepatocytes Sales in Volume by Country (2017-2028)
10.3.2 South America Primary Hepatocytes Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Primary Hepatocytes Sales by Type (2017-2028)
11.2 Middle East & Africa Primary Hepatocytes Sales by Application (2017-2028)
11.3 Middle East & Africa Primary Hepatocytes Market Size by Country
11.3.1 Middle East & Africa Primary Hepatocytes Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Primary Hepatocytes Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Primary Hepatocytes and Key Manufacturers
12.2 Manufacturing Costs Percentage of Primary Hepatocytes
12.3 Primary Hepatocytes Production Process
12.4 Primary Hepatocytes Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Primary Hepatocytes Typical Distributors
13.3 Primary Hepatocytes Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 初代肝細胞の世界市場2022：ヒト初代細胞、動物初代細胞(Global Primary Hepatocytes Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

初代肝細胞の世界市場2022：ヒト初代細胞、動物初代細胞

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp